Compounds made from Adamantilidida derivatives and receptor 5 glutamate metabolite (MGLUR5) of Western Sahara modulator; pharmacological synthesis containing these substances; and used in the treatment of SNC diseases or disorders, such as depression, anxiety disorders, schizophrenia and Parkinson's disease.

摘要

p Adamantildiamide-derived compounds, allosteamic modulators of the metabotropic glutamate 5 receptor; pharmaceutical composition that includes them; and use to treat a CNS disease or disorder such as depression, anxiety, schizophrenia, and Parkinson's disease. /p